Role of burkholderia pseudomallei biofilm formation and lipopolysaccharide in relapse of melioidosis

Clinical Microbiology and Infection

Volumn 20, Issue 11, 2014, Pages O854-O856

  Limmathurotsakul, D ^a   Paeyao, A ^b   Wongratanacheewin, S ^b   Saiprom, N ^a   Takpho, N ^a   Thaipadungpanit, J ^a   Chantratita, N ^a   Wuthiekanun, V ^a   Day, N P J ^a,c   Peacock, S J ^a,d  

^a MAHIDOL UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

pseudomallei; Biofilm; Lipopolysaccharide; Melioidosis; Relapse

Indexed keywords

ANTIBIOTIC AGENT; LIPOPOLYSACCHARIDE;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; BIOFILM; BLOOD CULTURE; BURKHOLDERIA PSEUDOMALLEI; FEMALE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MELIOIDOSIS; NONHUMAN; OPTICAL DENSITY; PRIORITY JOURNAL; PUBLIC HEALTH; RELAPSE; RISK FACTOR; CASE CONTROL STUDY; CHEMISTRY; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PHYSIOLOGY; RECURRENT DISEASE;

BURKHOLDERIA PSEUDOMALLEI;

ADULT; BIOFILMS; BURKHOLDERIA PSEUDOMALLEI; CASE-CONTROL STUDIES; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; MALE; MELIOIDOSIS; MIDDLE AGED; RECURRENCE;

EID: 84917689788     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12614     Document Type: Article

References (12)

1. Limmathurotsakul D, Peacock SJ. Melioidosis: a clinical overview. Br Med Bull 2011; 99: 125-139.
2. Limmathurotsakul D, Wongratanacheewin S, Teerawattanasook N et al. Increasing incidence of human melioidosis in Northeast Thailand. Am J Trop Med Hyg 2010; 82: 1113-1117.
3. Maharjan B, Chantratita N, Vesaratchavest M et al. Recurrent melioidosis in patients in northeast Thailand is frequently due to reinfection rather than relapse. J Clin Microbiol 2005; 43: 6032-6034.
4. Limmathurotsakul D, Chaowagul W, Chantratita N et al. A simple scoring system to differentiate between relapse and re-infection in patients with recurrent melioidosis. PLoS Negl Trop Dis 2008; 2: e327.
5. Limmathurotsakul D, Chaowagul W, Chierakul W et al. Risk factors for recurrent melioidosis in northeast Thailand. Clin Infect Dis 2006; 43: 979-986.
6. Soto SM, Smithson A, Horcajada JP, Martinez JA, Mensa JP, Vila J. Implication of biofilm formation in the persistence of urinary tract infection caused by uropathogenic Escherichia coli. Clin Microbiol Infect 2006; 12: 1034-1106.
7. Lewis K. Persister cells, dormancy and infectious disease. Nat Rev Microbiol 2007; 5: 48-56.
8. Falagas ME, Kapaskelis AM, Kouranos VD, Kakisi OK, Athanassa Z, Karageorgopoulos DE. Outcome of antimicrobial therapy in documented biofilm-associated infections: a review of the available clinical evidence. Drugs 2009; 69: 1351-1361.
9. Anuntagool N, Wuthiekanun V, White NJ et al. Lipopolysaccharide heterogeneity among Burkholderia pseudomallei from different geographic and clinical origins. Am J Trop Med Hyg 2006; 74: 348-352.
10. Stepanovic S, Vukovic D, Dakic I, Savic B, Svabic-Vlahovic M. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods 2000; 40: 175-179.
11. Sawasdidoln C, Taweechaisupapong S, Sermswan RW, Tattawasart U, Tungpradabkul S, Wongratanacheewin S. Growing Burkholderia pseudomallei in biofilm stimulating conditions significantly induces antimicrobial resistance. PLoS One 2010; 5: e9196.
12. Taweechaisupapong S, Kaewpa C, Arunyanart C et al. Virulence of Burkholderia pseudomallei does not correlate with biofilm formation. Microb Pathog 2005; 39: 77-85.